As shown in Figure 5A, during CCH development, the ratios of p-JAK2:t-JAK2 and p-STAT3:t-STAT3 were significantly upregulated in all of the treatment groups as compared with those of the CCH rats (p < 0.01; Figure 5B). This evidence concerns the gene JAK2 and columnar cell hyperplasia of the breast.